Pzena Investment Management LLC trimmed its position in Genpact Limited (NYSE:G - Free Report) by 37.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 732,142 shares of the business services provider's stock after selling 431,717 shares during the quarter. Pzena Investment Management LLC owned about 0.42% of Genpact worth $36,885,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Proficio Capital Partners LLC bought a new position in Genpact in the 4th quarter worth approximately $983,000. Raymond James Financial Inc. bought a new position in shares of Genpact during the 4th quarter valued at approximately $5,552,000. PNC Financial Services Group Inc. boosted its position in shares of Genpact by 4.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 14,468 shares of the business services provider's stock valued at $621,000 after acquiring an additional 550 shares during the last quarter. HighTower Advisors LLC boosted its position in shares of Genpact by 112.2% during the 4th quarter. HighTower Advisors LLC now owns 12,573 shares of the business services provider's stock valued at $540,000 after acquiring an additional 6,647 shares during the last quarter. Finally, Swiss National Bank purchased a new stake in Genpact during the 4th quarter valued at $14,298,000. 96.03% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, Director Nicholas C. Gangestad acquired 2,000 shares of the stock in a transaction on Tuesday, May 13th. The shares were bought at an average price of $43.97 per share, with a total value of $87,940.00. Following the completion of the purchase, the director owned 2,000 shares of the company's stock, valued at approximately $87,940. This represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.80% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have weighed in on the company. Mizuho increased their target price on Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 1st. Wall Street Zen upgraded Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Deutsche Bank Aktiengesellschaft started coverage on Genpact in a research note on Thursday. They set a "hold" rating and a $47.00 price target on the stock. Robert W. Baird cut their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research note on Thursday, May 8th. Finally, Needham & Company LLC restated a "buy" rating and set a $50.00 price target on shares of Genpact in a research note on Monday, June 30th. Five research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $49.75.
Get Our Latest Analysis on Genpact
Genpact Stock Performance
NYSE:G traded down $0.09 during trading hours on Friday, reaching $45.37. The company had a trading volume of 792,344 shares, compared to its average volume of 1,426,453. Genpact Limited has a 1-year low of $32.18 and a 1-year high of $56.76. The firm has a market cap of $7.93 billion, a PE ratio of 15.48, a price-to-earnings-growth ratio of 1.73 and a beta of 0.94. The business's 50 day moving average price is $43.75 and its 200-day moving average price is $47.16. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.45 and a quick ratio of 2.45.
Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. The business had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. Genpact had a return on equity of 22.35% and a net margin of 10.88%. The business's revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.73 earnings per share. Research analysts forecast that Genpact Limited will post 3.21 EPS for the current year.
Genpact Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date is Thursday, September 11th. Genpact's dividend payout ratio (DPR) is currently 23.21%.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.